Prenatal chromosomal microarray (CMA) is a test that is used to diagnose certain genetic problems in the fetus. While the test has been used in the pediatric setting for several years, it is now being introduced for use in the prenatal setting. The test offers great hope for detection of certain genetic defects in the fetus so that early intervention can be performed to improve the outcome for that individual. As with many biotechnical advances, CMA comes with certain bioethical issues that need to be addressed prior to its implementation. This paper is intended to provide guidance to all those that provide counseling regarding genetic testing options during pregnancy.
ACOG Practice Bulletin # 77. January 2007. Screening for chromosomal abnormalities.
2.
AdzickN.S., ThomE.A., SpongC.Y., BrockJ.W., BurrowsP.K., JohnsonM.P., HowellL.J., FarrellJ.A., DabrowiakM.E., SuttonL.N., GuptaN., TulipanN.B., D'AltonM.E., and FarmerD.L.2011. A randomized trial of prenatal versus postnatal repair of myelomeningocele. New England Journal of Medicine364: 993–1004.
3.
BeckmanJ.S., EstivallE., and AntonarakisS.E.2007. Copy number variants and genetic traits: Closer to the resolution of phenotypic and genotypic variability. Nature Reviews, Genetics8: 639–46.
4.
BodurthaJ., and StraussJ.F.2012. Genomics and prenatal care. New England Journal of Medicine366: 64–73.
5.
ClampM., FryB., KamalM., XieX., CuffJ., LinM.F., KellisM., Lindblad-TohK., and LanderE.S.2007. Distinguishing protein-coding and noncoding genes in the human genome. Proceedings of National Academy of Science USA104: 19428–33.
6.
Congregation for the Doctine of the Faith (CDF). 1987. Donum vitae.
7.
DavidsonE.H., and LevineM.S.2008. Properties of developmental gene regulatory networks. PNAS105: 20063–66.
8.
DugoffL.2012. Application of genomic technology in prenatal diagnosis. New England Journal of Medicine367: 2249–50.
9.
FeeroW.G., GuttmacherA.E., and CollinsF.S.2010. Genomic medicine - a primer. New England Journal of Medicine362: 2001–11.
10.
FrancisPope. 2013. Lumen fidei, nn. 2, 3.
11.
GetzL., and KirkengenA.L.2003. Ultrasound screening in pregnancy: Advancing technology, soft markers for fetal chromosomal aberrations, and acknowledged ethical dilemmas. Social Science Medicine56: 2045–57.
LeslieL.K., and BoyceT.1996. Consultation with the specialist: The vulnerable child. Pediatrics in Review17: 323–6.
15.
MayaI., DavidovB., GershovitzL., ZalzsteinY., TaubE., ChoppingerJ., ShafferL.G., and ShomatM.2010. Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting. Prenatal Diagnosis30: 1131–7.
16.
McGillivrayG., RosenfeldJ.A., McKinlay GardnerJ.A., and GillamL.H.2012. Genetic counseling and ethical issues with chromosome microarray analysis in prenatal testing. Prenatal Diagnosis32: 389–95.
17.
MeffordH.C., BatshawM.L., and HoffmanE.P.2012. Genomics, intellectual disability and autism. New England Journal of Medicine366: 733–43.
18.
MillerD.T., AdamM.P., AradhyaS., BiesecherL.G., BrithmanA.R., CarterN.P., ChurchD.M., CrollaJ.A., EichlerE.E., EpsteinC.J., FaucettW.A., FeukL., FriedmanJ.M., HomashA., JacksonL., KaminskyE.B., KokK., KrantzI.D., KuhnR.M., LeeC., OstellJ.M., RosenbergC., SchererS.W., SpinnerN.B., StavropoulosD.J., TepperbergJ.H., ThorlandE.C., VermeeschJ.R., WagginerD.J., WatsonM.S., MartinC.L., and LedbetterD.H.2010. Consensus Statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics86: 749–64.
19.
NatoliJ.L., AckermanD.L., McDermottS., and EdwardsJ.G.2012. Prenatal diagnosis of Down syndrome: A systematic review of termination rates (1995–2011). Prenatal Diagnosis32: 142–53.
20.
PacholczykT.2006. Temptations in prenatal testing. National Catholic Bioethics Center Educational Programs: Making sense out of bioethics. http://www.ncbcenter.org/page.aspx?pid=286.
21.
ParkJ.H., WooJ.H., ShimS.H., YangS.J., ChoiY.M., YandK.S., and ChaD.H.2010. Application of a target array comparative genomic hybridization to prenatal diagnosis. BMC Medical Genetics11: 102.
22.
RedonR., IshikawaS., FitchK.R., FeukL., PerryG.H., Daniel AndrewsT., FieglerH., ShaperoM.H., CarsonA.R., ChenW., Kyung ChoE., DallaireS., FreemanJ.L., GonzálezJ.R., GratacòsM., HuangJ., KalaitzopoulosD., KomuraD., MacDonaldJ.R., MarshallC.R., MeiR., MontgomeryL., NishimuraK., OkamuraK., ShenF., SomervilleM.J., TchindaJ., ValsesiaA., WoodwarkC., YangF., ZhangJ., ZerjalT., ZhangJ., ArmengolL., ConradD.F., EstivillX., Tyler-SmithC., CarterN.P., AburataniH., LeeC., JonesK.W., SchererS.W., and HurlesM.E.2006. Global variation in copy number in the human genome. Nature444: 444–54.
23.
RodeckC.H., KempJ.R., HolmanC.A., WhitmoreD.N., KarnickiJ., and AustinM.A.1981. Direct intravascular fetal blood transfusion by fetoscopy in severe Rhesus isoimmunization. Lancet8221: 625–7.
24.
SagooG.S., ButterworthA.S., SandersonS., Shaw-SmithC., HigginsJ.P., and BurtonH.2009. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: Updated systematic review and meta-analysis of 19 studies and 13,926 patients. Genetics in Medicine11: 139–46.
25.
StrebniakM., BoterM., OudesluijsG., JoostenM., GovaertsL., van OpstalD., and GaljaardR.J.2011. Application of SNP array for rapid prenatal diagnosis: Implementation, genetic counseling and diagnostic flow. European Journal of Human Genetics19: 1230–7.
26.
WapnerR.J., MartinC.L., LevyB., BallifB.C., EngC.M., ZacharyJ.M., SavageM., PlattL.D., SaltzmanD., GrobmanW.A., KlugmanS., SchollT., SimpsonJ.L., McCallK., AggarwalV.S., BunkeB., NahumO., PatelA., LambA.N., ThomE.A., BeaudetA.L., LedbetterD.H., ShafferL.G., and JacksonL.2012. Chromosomal microarray versus karyotyping for prenatal diagnosis. New England Journal of Medicine367: 2175–84.
27.
WongK.K., deLeeuwR.J., DosanjhN.S., KimmL.R., ChengZ., HorsmanD.E., MacAulayC., NgR.T., BrownC.J., EichlerE.E., and LamW.L.2007. A comprehensive analysis of common copy-number variations in the human genome. American Journal of Human Genetics80: 91–104.
